The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table 3.

Comparisons of uACR and the quartiles of the UA/HDL-C ratio

Category uACR (mg/g) (N=5,845)
Model 1 Model 2 Model 3 Model 4
UA/HDL-C ratio
Quartile 1 18.45±3.36 (11.86∼25.05) 18.10±3.60 (11.04∼25.17) 19.58±3.58 (12.56∼26.60) 19.10±3.63 (11.98∼26.21)
Quartile 2 18.83±3.36 (12.25∼25.41) 18.68±3.40 (12.02∼25.35) 19.96±3.38 (13.35∼26.58) 19.80±3.38 (13.17∼26.43)
Quartile 3 23.96±3.37 (17.35∼30.56) 24.09±3.41 (17.42∼30.77) 23.29±3.38 (16.67∼29.91) 23.39±3.38 (16.76∼30.02)
Quartile 4 38.38±3.36 (31.79∼44.97) 38.74±3.62 (31.65∼45.83) 36.91±3.60 (29.86∼43.96) 37.46±3.66 (30.28∼44.64)
P-value <0.001 <0.001 <0.001 0.002

Model 1, adjusted for age; Model 2, Model 1 further adjusted for gender; Model 3, hypertension, obesity, and T2DM; Model 4, Model 3 further adjusted for CKD. Non-albuminuria, uACR<30; Albuminuria, uACR≥30; Hypertension, SBP≥140 mmHg or DBP≥90 mmHg or medication; Obesity, BMI≥25 kg/m2; T2DM, FBG≥126 mg/dL or medication; CKD, eGFR≥60 mL/min/1.73 m2.

Mean±standard error (95% confidence interval).

Abbreviation: uACR, urine microalbumin to urine creatinine ratio; UA, uric acid; HDL-C, high density lipoprotein cholesterol.

Korean J Clin Lab Sci 2023;55:167-73 https://doi.org/10.15324/kjcls.2023.55.3.167
© 2023 Korean J Clin Lab Sci